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We report a patient with febrile illness and epidemio-
logic and clinical findings consistent with human granulo-
cytic ehrlichiosis and tickborne encephalitis, in whom
infection with Anaplasma phagocytophilum was demon-
strated by polymerase chain reaction and seroconversion.
Tickborne encephalitis virus infection was established by
serum immunoglobulin (Ig) M and IgG antibodies.
T
icks transmit several bacteria, viruses, and parasites
capable of infecting and causing diseases in humans.
In general, only a small proportion of bites from infected
ticks result in infection, and only a fraction of these infec-
tions result in clinical illnesses such as Lyme borreliosis,
ehrlichioses, rickettsioses, tickborne encephalitis (TBE),
and babesiosis. Infection does not inevitably indicate the
presence of the illness nor does it always allow for a reli-
able explanation of all the signs and symptoms a patient
may have. Many distinct causative agents transmitted by
the same vector make coinfection and, consequently, the
simultaneous presence of more than 1 tickborne disease
possible. Human coinfection may occur from a bite of a
single tick that transmits multiple pathogens or from mul-
tiple tick bites; sequential infections can occur from bites
taking place at different times. 
Although several reports of coinfection (some of them
most probably sequential infections) with tick-transmitted
agents have been made, rather limited information exists
on the simultaneous clinical features of corresponding ill-
nesses (1). Reports from the United States involve cases
with concurrent Lyme disease, babesiosis, or human gran-
ulocytic ehrlichiosis (HGE). In addition, U.S. studies indi-
cate that the frequency of simultaneous diseases caused by
infection with >1 tickborne pathogen is usually low and
varies among geographic locations (1,2). Data from
Europe are limited to the reports on coinfections with TBE
virus and Borrelia burgdorferi sensu lato (s.l.) in patients
with acute meningitis (3–7). Other combinations that could
have also been possible in European populations, includ-
ing infections with Anaplasma phagocytophilum,  B.
burgdorferi s.l., or TBE virus, have been so far indicated
only by the findings of serosurvey studies (8–11). 
Slovenia is a small central European country where
TBE, Lyme borreliosis, and HGE are known to be endem-
ic. Residents of Slovenia are often exposed to ticks and
thus at risk of acquiring infection with multiple tickborne
pathogens (7). We report on a patient with TBE and HGE
in whom infection with A. phagocytophilum was demon-
strated by polymerase chain reaction (PCR) and serocon-
version, and TBE virus infection was established by the
presence of immunoglobin (Ig)M and IgG antibodies to
TBE virus in serum. 
Case Report
On May 2, 2003, a 47-year-old-woman, who lived in
northwestern Slovenia, was admitted to the Department of
Infectious Diseases, University Medical Centre Ljubljana,
Slovenia, with a 7-day history of fever <40.0°C, severe
headache, nausea, dry cough, malaise, intense myalgia,
and arthralgia. She recalled having sustained 3 tick bites
on her abdomen during the previous month. The last bite
occurred 14 days before onset of her illness while she was
walking in the woods near her home; no skin lesions
appeared at the site of the bites. Her previous medical his-
tory was unremarkable. She had not been vaccinated
against TBE, nor had she traveled outside Slovenia during
the last few years.
When she sought treatment, her body temperature was
38.5°C, pulse rate was 90 beats/min, and blood pressure
was 110/70 mm Hg. With the exception of fever, the phys-
ical examination did not show any notable abnormality;
rash and meningeal signs were not present. Routine labo-
ratory tests showed leukopenia, thrombocytopenia, abnor-
mal liver function test results, elevated concentration of
serum C-reactive protein, and elevated procalcitonin levels
(Table 1). A chest radiograph showed no abnormalities.
Amoxicillin−clavulanic acid was prescribed. The fever
subsided in 3 days (on day 10 after the onset of her illness),
and the patient was discharged from the hospital. Her con-
dition improved, but the headache persisted and intensi-
fied. On May 13, she was reexamined in our department,
and lumbar puncture was performed. Cerebrospinal fluid
examination showed normal protein and glucose concen-
trations but a mildly elevated number of leukocytes (7 x
106/L). At subsequent evaluations, the patient reported
feeling better. On day 20 after onset, the control laborato-
ry test results, including liver function test results, were
within the normal range. 
Several microbiologic procedures, including those for
determining infections with A.  phagocytophilum,
Ehrlichia chaffeensis, B. burgdorferi s.l., and TBE virus,
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Giemsa-stained peripheral blood smear examination by
light microscopy for the presence of ehrlichial morulae
within leukocytes was negative. Serum samples were test-
ed by an indirect immunofluorescence assay for the pres-
ence of specific IgG antibodies to A. phagocytophilum
(strain USG3 propagated in HL60 promyelocyte cells),
IgM and IgG antibodies to E. chaffeensis antigens (MRL
Diagnostics, Cypress, California, USA), and IgM and IgG
antibodies to B. burgdorferi s.l (whole cells of a local iso-
late of B. afzelii were used as an antigen). The presence of
serum TBE virus IgM and IgG antibodies was assessed by
enzyme-linked immunosorbent assay (ELISA) (Dade
Behring Marburg GmbH, Marburg, Germany). The results
of serologic tests indicating recent infection with A.
phagocytophilum and TBE virus are depicted in Table 2.
Primers Ehr521 and Ehr790, which amplified the 16S
rRNA gene of A. phagocytophilum, produced a fragment
of the expected size (293 bp) in the acute-phase blood
specimen (Figure) (12). No nucleic acids were amplified
with primers specific for E. chaffeensis HE1 and HE3
(Table 2) (13).
Conclusions
Few reports have been published on serologic evidence
of coinfection with TBE virus and A. phagocytophilum in
Europe. The results on groups of persons representing dif-
ferent risk categories for tick exposure in Switzerland pro-
vided serologic evidence of coinfection with A.
phagocytophilum and TBE virus (9). Weber et al., who ret-
rospectively tested serum specimens of patients with Lyme
borreliosis or TBE for antibodies to A. phagocytophilum,
reported similar findings (10). Although serologic data
suggested coinfection with A. phagocytophilum and TBE
virus, no confirmation of acute HGE was obtained among
the residents of Switzerland.In the Czech Republic, where
TBE is endemic, among 67 patients hospitalized for TBE,
6 (9%) were seropositive to A. phagocytophilum (11). In
Slovenia, the background seroprevalence of HGE in chil-
dren and young adults (15%) was found to be similar to
that of Lyme borreliosis (15%) and TBE (13%) (14). In
addition, a prospective study was performed to establish
the etiologic agents of acute febrile illnesses that occurred
within 6 weeks after a tick bite in residents of Slovenia, by
using a combination of microbiologic and clinical criteria.
Out of 130 adult patients, 36 (28%) had laboratory evi-
dence of TBE virus infection (all had clinically confirmed
disease), whereas 4 of 22 (17%) patients with the evidence
of  A.  phagocytophilum infection, had confirmed HGE.
Infection by multiple organisms (>1) was found in 19
(15%) of 130 patients. Four of them had confirmed TBE
and also met the study criteria for probable HGE but not
for confirmed HGE (7).
The clinical signs and symptoms of HGE are unspecif-
ic and usually consist of fever, headache, chills, malaise,
myalgia, or arthralgia, which often occur after a tick bite.
Laboratory analysis shows leukopenia, thrombocytopenia,
lymphopenia, elevated activity of hepatic enzymes, and an
elevated concentration of C-reactive protein (7). However,
leukopenia and thrombocytopenia are common not only in
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which they were found in 67% and 71% of patients,
respectively (15). For most patients in whom TBE devel-
ops, the disease has a biphasic course. Our patient, howev-
er, had a monophasic course of febrile illness, which was
observed in 27% of patients with TBE in Slovenia (16). 
In our report, the diagnosis of TBE was established by
the presence of a febrile illness after a tick bite with
headache, mild lymphocytic pleocytosis, and demonstra-
tion of serum IgM and IgG antibodies to TBE virus by
ELISA, the serologic method of choice with the specifici-
ty 99.9% for IgM and 99.5% for IgG and the sensitivity
99.8% and 96.8% for IgM and IgG, respectively (17). The
presence of TBE IgM antibodies 144 days after the onset
of illness in our patient (Table 2) is not surprising because
the IgM antibodies as a rule persist for several months after
acute infection (17). However, changes in antibody titers
as demonstrated in our patient attest for recent infection.
The febrile illness associated with leukopenia, thrombocy-
topenia, an elevated concentration of serum C-reactive
protein, and the demonstration of A. phagocytophilum
infection by seroconversion as well as a positive PCR
result also met the criteria for confirmed HGE. To our
knowledge, the patient reported herein represents the first
case of concurrent confirmed TBE and confirmed HGE.
Some reports suggest that coinfection with more than 1
tickborne pathogen may influence the natural history of
each of the corresponding diseases, making the clinical
course more severe and the outcome less favorable (1). In
spite of proven coinfection and fulfillment of criteria for
confirmed TBE and HGE (and the absence of treatment
with doxycycline, which could have influenced the natural
course of HGE), our patient had a relatively mild illness
with uneventful recovery. However, the information
obtained from a single patient does not allow for a reliable
conclusion on the potential influence of TBE virus and A.
phagocytophilum coinfection on the clinical features and
course of the combined illness.
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lane 4 positive control (DNA extracted from the cultured isolate of
A. phagocytophilum). Lane M represents a 100-bp DNA ladder for
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